Development

Editor of Pharmaceutical Technology Europe

Articles

Particle engineering can be a resourceful tool to advance drug candidates by offering drug delivery innovation. 

A Deep Dive into Particle Engineering as a Drug Delivery Tool

Meg Rivers is the former senior editor for 

While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.

Advances in Drug Delivery and Areas for Improvement

Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.

An Evolving Approach to Drug Delivery 

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.

Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance a Treatment for Multiple Myeloma

Feliza Mirasol is the science editor for 

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Next-Gen Technologies Tackle Drug Delivery Challenges

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.

Evonik and Stanford University Partner to Develop mRNA Drug Delivery Technology

Eli Lilly and Company has partnered with leading diabetes tech firms to offer app compatibility with insulin smart pens to streamline diabetes management with automated data collection.

Lilly Forms Pact with Diabetes Tech Companies to Integrate Connected Insulin Pen Solutions

The inhaled route of administration for biologics is experiencing renewed interest, particularly in light of the COVID-19 pandemic.

Taking a Breath: Advances in Inhaled Biologics

Nanoform and Herantis have signed a biologics proof of concept agreement for formulation proof of concept projects aimed at improving nasal drug delivery to the brain.